| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |